NCT00037804: Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction |
|
|
| Completed | 1 | | US | Irinotecan | Pfizer | Unspecified Adult Solid Tumor, Chemotherapy, Liver Dysfunction, Neoplasms, Solid Tumor | | | | |
NCT00861783: Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma |
|
|
| Completed | 1 | 16 | US | irinotecan and ON 01910.Na, camptothecin-11, irinotecan HCl, Camptosar, CPT-11, diaminocyclohexane oxalatoplatinum, rigosertib sodium, oxaliplatin and ON 01910.Na, Eloxatin, oxaloplatinum, oxalatoplatin | Onconova Therapeutics, Inc. | Hepatoma, Advanced Solid Tumor | 07/11 | 07/11 | | |
NCT00537121: Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer |
|
|
| Completed | 1 | 23 | US | fluorouracil, irinotecan hydrochloride, leucovorin calcium, vorinostat, pharmacological study | Roswell Park Cancer Institute, Merck Sharp & Dohme LLC | Esophageal Cancer, Gastric Cancer, Liver Cancer | 10/12 | 06/13 | | |
